This move is archived. Current quotes and coverage live on the stock page.
Get MBX alerts:
Microbix Biosystems Inc. is seeing a noticeable increase in its stock price, reflecting positive market sentiment.
Microbix Biosystems Inc. (MBX.TO) shares are up 3.33% today, reaching CA$0.31. This rise comes as the company continues to grow in the biotechnology sector.
Advertisement
Microbix Biosystems Inc.
MBX.TO
MBX.TO
Microbix Biosystems Inc.
WealthAwesomeMarket cap
$42.46M
52W high
$0.33
52W low
$0.21
1W change
+5.08%
Beta
0.57
Analyst Price Targets
Based on analyst covering MBX · as of Sep 17, 2026
Wall Street analysts forecast MBX stock price to rise 29.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.40
+29.0% Upside
Current Price
C$0.31
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
58.9%
Annualized
90-Day Vol
54.2%
Annualized
Trend (90d)
+13.8%
Annualized drift
90d Mean
C$0.33
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.32 | C$0.26 – C$0.39 |
| 60 trading days | C$0.32 | C$0.24 – C$0.43 |
| 90 trading days | C$0.33 | C$0.23 – C$0.46 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors might find potential in Microbix's recent performance and upcoming financial disclosures, as the company works to strengthen its market position.
Microbix Biosystems Inc. Market Cap Reaches CA$41.25 Million
With a market cap of CA$41.25 million, Microbix operates in a niche area of the biotechnology industry, presenting both risks and opportunities for investors.
Bull case
The recent increase in stock price suggests that investors are gaining confidence in Microbix's strategic plans and its ability to grow its market share.
Bear case
Even with today's gains, the company faces challenges, such as a negative profit margin and the need for consistent revenue growth to attract long-term investors.
Recent Performance Overview
Advertisement
Microbix Biosystems Inc. has experienced a significant positive shift in its stock price today, with a 3.33% increase. This uptick is part of the company’s strategic efforts to expand its product offerings and market presence.
Market Sentiment and Future Prospects
The rise in Microbix's stock price may indicate growing investor confidence in the company’s future. With financial results expected soon, stakeholders are closely watching how the company will report its progress and growth strategies. Investors can learn more about Microbix's performance on our stock page.
Understanding the Risks
While the stock is rising today, investors should keep in mind the inherent risks, including the company’s current negative profit margin. As Microbix aims to strengthen its market position, potential investors should carefully weigh these factors against today’s positive performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
